Poland's Diagnostyka reports $17.5 million second quarter profit
Published by Global Banking and Finance Review
Posted on September 4, 2025
1 min readLast updated: January 22, 2026

Published by Global Banking and Finance Review
Posted on September 4, 2025
1 min readLast updated: January 22, 2026

Diagnostyka reports a $17.5M profit in Q2, driven by increased test sales and strategic acquisitions in diagnostic imaging.
GDANSK (Reuters) -Polish medical laboratory operator Diagnostyka, which listed on the stock exchange in February, reported a second-quarter net profit of 63.8 million zlotys ($17.53 million) on Thursday, driven by rising sales of tests and a higher average price per test.
The company continues its strategy of expanding through acquisitions, particularly in the field of diagnostic imaging. In July, Diagnostyka acquired NZOZ Pracownia Genetyki Nowotworów and a majority stake in VITA-SKAN.
"We are currently engaged in further acquisition discussions with several potential targets. While not every M&A negotiation leads to a deal, we expect to finalise more acquisitions in the medical imaging field this year," CEO Jakub Swadzba said in a statement.
Diagnostyka said its second-quarter operating revenue rose to 593.4 million zlotys from 591.6 million zlotys reported last quarter.
Its recurring EBITDA for the first half of the year came in at 314.1 million zlotys.
($1 = 3.6405 zlotys)
(Reporting by Julia Kotowska; Editing by Susan Fenton)
Net profit is the amount of money a company earns after all expenses, taxes, and costs have been deducted from total revenue. It is a key indicator of a company's profitability.
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a company's overall financial performance and profitability from operations.
An acquisition is a corporate action in which one company purchases most or all of another company's shares to gain control. It is often used as a growth strategy.
Revenue growth refers to the increase in a company's sales over a specific period. It is an important metric that indicates the company's ability to expand its business.
Explore more articles in the Finance category


